Premium
Impetigo: A Reassessment of Etiology and Therapy
Author(s) -
Barton Leslie L.,
Friedman Allan D.
Publication year - 1987
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.1987.tb00776.x
Subject(s) - impetigo , medicine , penicillin , etiology , bacteriology , dermatology , microbiology and biotechnology , staphylococcus aureus , antibiotics , bacteria , biology , genetics
Traditional concepts regarding the bacteriology and therapy of non‐bullous impetigo have been reexamined. Although in the United States the disease is considered primarily of streptococcal origin and amenable to penicillin therapy, we found that Staphyiococcus aureus was the most common isolate in 71 patients studied. Only two patients yielded pure cultures of group A β‐hemolytic streptococci. All but two isolates of S. aureus were resistant to penicillin; one of these two isolates was aiso resistant to erythromycin. Eryth‐romycin appeared to be more efficacious than penicillin for the treatment of impetigo.